https://www.avient.com/sites/default/files/2022-04/MEVOPUR LQ for Silicone Elastomers.pdf
Customized color solutions are
available on request
• Production under ISO 13485 / GMP quality
system with change control management
• Fingerprinting of raw materials and routine
batch testing
• Extractability evaluated in hexane, isopropanol,
and water according
to ISO 10993 part 18
REGULATORY SUPPORT
• Raw materials are pre-tested to biologically-
evaluated raw materials using ISO 10993-1 and
USP chapters , Class VI
• DMF/MAF documentation filed with the FDA
for all standard colors
APPLICATIONS
MEVOPUR LQ formulations can be applied
in demanding applications including:
• Medical devices such as catheter tubing
& connectors, syringe tips, and needleless
connectors
• Skin contact devices such as wearables
or soft-touch surfaces of medical devices
PRODUCT BULLETIN
MEVOPUR™-LQ YELLOW (PMS1205C)
Product Code FZ1M415005
MEVOPUR™-LQ TRANS YELLOW
Product Code FZ1M415006
MEVOPUR™-LQ BLUE (PMS292C)
Product Code FZ5M415008
MEVOPUR™-LQ TRANS BLUE
Product Code FZ5M415009
MEVOPUR™-LQ RED (PMS198C)
Product Code FZ3M415008
MEVOPUR™-LQ TRANS RED
Product Code FZ3M415009
MEVOPUR™-LQ GREEN (PMS346C)
Product Code FZ6M415008
MEVOPUR™-LQ TRANS GREEN
Product Code FZ6M415009
MEVOPUR™-LQ VIOLET (PMS2655C)
Product Code FZ4M415003
MEVOPUR™-LQ TRANS VIOLET
Product Code FZ4M415004
CUSTOM-MADE Individual options
Customized colors
are also available to
meet your needs,
please contact us.
Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for:
(1) exposure to human tissue or body fluids for 30 days or greater;
(2) “plastic” (cosmetic or reconstructive) surgery use;
(3) reproductive implants or any birth control device; or
(4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Annual%2520Report%2520for%252015%2520Tideman.pdf
Orangeville Plasticizer (Update 1) Report Preview
National Pollutant Release
Inventory (NPRI) and Partners
Home Submission Management Help My Profile:Brian Greer Logout Ec.gc.ca
Report Preview
Report Details
Company and Facility Details
Contacts Details
Report Year
2016
Report Type:
NPRI,ON MOE TRA
Report Status:
Update 1 Submitted
Modified Date/Time:
30/04/2018 3:36 PM
Report Update Comments:
As per requests from Catherine Siew
Company Name:
Polyone Canada Inc.
lang=En&n=3C401D5C-1
http://www.ec.gc.ca/default.asp?
lang=En&n=BD3CE17D-1
http://www.ec.gc.ca/default.asp?
https://www.avient.com/sites/default/files/2020-07/avient-abac-vietnam-200721_0.pdf
Chính sách Toàn
cầu về Chống Hối
lộ và Chống Tham
nhũng của Avient
Ban hành: Ngày 01/7/2020
Mục lục
Chính sách Toàn cầu về Chống Hối lộ và Chống Tham nhũng 1
Tầm quan trọng của việc Tuân thủ 1
Trách nhiệm của chúng ta 1
Hối lộ là gì?
2
Hối lộ Viên chức Chính phủ 2
Hối lộ Thương mại 3
Thanh toán Bôi trơn và Lại quả 3
Làm việc với Đại lý, Nhà phân phối và các Bên Thứ ba Khác 3
Quy trình Thẩm định và Phê duyệt 3
Dấu hiệu Cảnh báo 4
Yêu cầu về Kế toán và Lưu giữ Hồ sơ 4
Báo cáo các vi phạm có thể xảy ra 4
Đường dây nóng về Đạo đức của Avient 5
Bảo vệ khỏi sự trả đũa 5
Tham khảo nhanh: NHỮNG VIỆC PHẢI LÀM VÀ KHÔNG ĐƯỢC LÀM VỀ ABAC 6
1
Chính sách Toàn cầu về Chống Hối lộ
và Chống Tham nhũng
Avient nghiêm cấm hành vi gian lận, hối lộ và tham
nhũng tất cả các hoạt động kinh doanh của chúng
tôi ở bất cứ đâu trên thế giới.
Mục lục
Bắc Mỹ
Trụ sở chính Avon Lake, Hoa Kỳ
33587 Walker Road Avon Lake,
OH, Hoa Kỳ
44012
Số điện thoại miễn phí:
+1 866 765 9663
Điện thoại: +1 440 930 1000
Fax: +1 440 930 3064
Châu Á Thái Bình Dương
Trụ sở Khu vực Thượng Hải,
Trung Quốc
2F, Block C 200 Đường Jinsu
Phố Đông, 201206 Thượng Hải,
Trung Quốc
Điện thoại: +86 (0) 21 6028 4888
Fax: +86 (0) 21 6028 4999
Nam Mỹ
Trụ sở Khu vực Sao Paulo,
Brazil
Av.
https://www.avient.com/sites/default/files/2020-07/pvc-extrusion-processors-case-study.pdf
A decrease in density of just 0.01–0.02 g/cc
can yield 4% annual savings in material consumption,
while generating a 4% increase in extruder productivity.
Powder CFA Pellet CFA ColorMatrix Excelite
Typical CFA
Density 0.52 g/cc
Excelite CFA
Density 0.50 g/cc
PF-1
Density 0.43 g/cc
PF-1
Density 0.339 g/cc
PF-1
Density 0.351 g/cc
https://www.avient.com/sites/default/files/2025-02/Hammerhead FR Flame Retardant Composite Panel for Building _ Construction Product Overview.pdf
Visit avient.com or
connect with us now
Property Unit
Hammerhead Composite
Panel (non-FR)
Hammerhead FR
Flame Retardant Panel
Areal Weight (lb/sqft) 1.15 1.34
Thickness (in) 1.02 1.02
Max Force* (lbf) 447 508
Modulus* (ksi) 323 321
Flexural Rigidity* (lb*in^2) 85,000 84,000
R-Value (/in) 4 4
MECHANICAL PROPERTIES
* ASTM D7249, 22” support span 4-point bend
Hammerhead FR Flame Retardant Panel
Panel Thickness 1 in. 4 in.
https://www.avient.com/sites/default/files/resources/POL%2520Sidoti%2520IR%2520Presentation%2520w%2520Non%2520GAAP%25203%252018%25202014.pdf
Use of Non-GAAP Measures
Page 3
PolyOne Commodity to Specialty Transformation
Page 4
• Continue specialty
transformation
• Targeting $2.50
Adjusted EPS by
2015, nearly
double 2013 EPS
• Drive double digit
operating income
and adjusted EPS
growth
• 17 consecutive
quarters of double-
digit adjusted EPS
growth
• Shift to faster
growing, high
margin, less cyclical
end markets
• Key acquisitions
propel current and
future growth, as
well as margin
expansion
• Established
aggressive 2015
targets
• Steve Newlin
Appointed,
Chairman, President
and CEO
• New leadership
team appointed
• Implementation of
four pillar strategy
• Focus on value
based selling,
investment in
commercial
resources and
innovation to drive
transformation
• Volume driven,
commodity
producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2013 2014 and beyond
-150.00%
-50.00%
50.00%
150.00%
250.00%
350.00%
PolyOne S&P 500 Russell 2000 Dow Jones Chemical
All time high of
$38.38
March 7th, 2014
• 17 consecutive quarters of
double digit EPS growth
• 49% CAGR adjusted EPS
expansion 2006-2013
• 2013 stock price increased
73% versus 30% growth in the
S&P
• More than seven fold increase in
market cap: $0.5b $3.6b
Strategy and Execution Drive Results
Page 5
Appliance
4%
Building &
Construction
13%
Wire & Cable
9%
Electrical &
Electronics
5%
Consumer
10%Packaging
16%
Industrial
12%
HealthCare
11%
Transportation
18%
Misc.
2%
United
States
66%
Europe
14%
Canada
7%
Asia
6%
Latin
America
7%
PP&S
20%
Specialty
53%
Distribution
27%
0.12
0.27 0.21
0.13
0.68
0.82
1.00
1.31
2.50
$0.00
$0.25
$0.50
$0.75
$1.00
$1.25
$1.50
$1.75
$2.00
$2.25
$2.50
2006 2007 2008 2009 2010 2011 2012 2013 2015
Target
A
dj
us
te
d
Ea
rn
in
gs
P
er
S
ha
re
2013 Revenues: $3.8 Billion
End Markets
2013 Revenues: $3.8 Billion
EPS
Page 6
PolyOne
At A Glance
Old
PolyOne Transformation
*Operating Income excludes corporate charges and special items
2%
34%
43%
62%
65-
75%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2015
%
o
f O
pe
ra
ti
ng
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
Specialty OI $5M $46M $87M $195M Target
Mix Shift Highlights Specialty Transformation
2015
Target
Page 7
2006 2013 2015
“Where we were” “Where we are” Target
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 12.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 9.3% 12 – 16%
Designed Structures & Solutions -- 5.6% 8 – 10%
Performance Products &
Solutions 5.4% 7.2% 9 – 12%
Distribution 2.6% 5.9% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 62% 65 – 75%
3) ROIC* (after-tax) 5.0% 9.1% 15%
4) Adjusted EPS Growth N/A 31%
Double Digit
Expansion
Proof of Performance & 2015 Goals
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 8
Bridge To $2.50 Adjusted EPS By 2015
2015 EPS: $2.50
2013 EPS: $1.31
Mid single digit
revenue CAGR
Page 9
Mergers & Acquisitions
Spartech accretion
Incremental share buybacks
Ongoing LSS Programs
(50-100 bps/yr)
Accelerated Innovation &
Mix Improvement
Innovation Drives Earnings Growth
$20.3
$52.3
2006 2013
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
*Percentage of Specialty Platform revenue from products introduced in last five years
Page 10
14.3%
30.7%
2006 2013
Specialty Platform
Gross Margin %
19.5%
43.0%
2006 2013
Healthcare
Consumer
Packaging and Additive Technology
Transportation
Page 11
Unique and Innovative Solutions that Help
Customers Win
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg
https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG
Net Debt / EBITDA* = 1.8x
$48
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Significant Debt Maturities
As of December 31, 2013
($ millions)
Page 12
Coupon Rates: 7.500% 7.375% 5.250%
Debt Maturities & Pension Funding – 12/31/13
*TTM 12/31/2013 ** includes US-qualified plans only
60%
100%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 2013
Pension Funding**
As of December 31, 2013
Free Cash Flow and Strong Balance Sheet Fund Investment
• Targets that expand our:
• Specialty offerings
• End market presence
• Geographic footprint
• Operating Margin
• Synergy opportunities
• Adjacent material solutions
• Expanding our sales,
marketing, and technical
capabilities
• Investing in operational and
LSS initiatives (including
synergy capture)
• Manufacturing alignment Organic
Growth
Share
Repurchases
Dividends
Acquisitions
Page 13
$0.16
$0.20
$0.24
$0.32
$0.00
$0.10
$0.20
$0.30
$0.40
2011 2012 2013 2014
Annual Dividend
• Repurchased ~5 million
shares in 2013
• 15 million shares
are available for
repurchase under
the current
authorization
The New PolyOne: A Specialty Growth Company
2015 Target: $2.50 Adjusted EPS
Why Invest In PolyOne?
Strong past performance demonstrates that our strategy and
execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation, incremental
pricing power, and competitive advantage
• Strong and proven management team driving growth and
performance
• Addressable market exceeds $40 billion
Page 14
1
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
Appendix
At a Glance�Global Specialty Engineered Materials
At a Glance�Global Color, Additives, and Inks
At a Glance�Designed Structures and Solutions
At a Glance�Performance Products and Solutions
At a Glance�Distribution
Plastics: Key to Future Sustainable Development
Establish Lean Six Sigma As Way of Life
Application Examples
Slide Number 24
2012 Range Rover Evoque Interior
Slide Number 26
Slide Number 27
Metal Replacement Solutions
High-Barrier Packaging Containers
Aerospace Applications
Sidoti Reconciliation of Non-GAAP.pdf
Section 1
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Annual%2520Report%2520for%252017%2520Tideman.pdf
lang=En&n=3C401D5C-1
http://www.ec.gc.ca/default.asp?
lang=En&n=BD3CE17D-1
http://www.ec.gc.ca/default.asp?
n=29E6BF9F-1&lang=en
http://www.ec.gc.ca/default.asp?
https://www.avient.com/resources/safety-data-sheets?page=4207
STAN-TONE MB- PINK 9/3
X HC 134121#SR-13030 Red
X HC 134121#SR-13031 Grey
https://www.avient.com/resources/safety-data-sheets?page=5967
ZHEA EBONY CDB210 25:1
ZHEA EBONY CDB210 10:1
X ET SR-33385 Tan Conc 3%
https://www.avient.com/resources/safety-data-sheets?page=6373
CM2157 TAN 3 HR
X 34931-0003A-01-1
X 34126-0003A-01-1